Inoviq (ASX:IIQ)
ASX announcement history & article coverage
Transparent by design.
Announcments by Inoviq (ASX:IIQ) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Quarterly Activities Report and Appendix 4C - June 2026
INOVIQ reports clinical validation setback for EXO-OC test but advances algorithm and CAR-exosome program with strong cash position
Investor Briefing on EXO-OC Test and study outcome
EXO-OC algorithm and clinical study update
Trading Halt
Notification of cessation of securities - IIQ
Positive CAR-exosome data in ovarian cancer
INOVIQ demonstrates strong in vitro tumour killing in ovarian cancer with CAR-exosomes
Response to ASX Price Query
INOVIQ Limited attributes share price rise to third-party research note on clinical milestones, confirms no undisclosed information
Change of Director's Interest Notice - Peter Gunzburg
Change of Director's Interest Notice - Peter Gunzburg
Change of Director's Interest Notice - Peter Gunzburg
Quarterly Activities Report and Appendix 4C - March 2026
INOVIQ advances ovarian cancer test clinical study and CAR-exosome therapeutics with strong cash position
